Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling-Reference-Cited by-同舟云学术

Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling

Published:2023-07 Issue:7 Volume:13 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Soltysova Andrea¹²,Dvorska Dana³,Kajabova Viera Horvathova⁴,Pecimonova Martina¹,Cepcekova Klaudia¹,Ficek Andrej¹,Demkova Lucia⁴,Buocikova Verona⁴,Babal Pavel⁵,Juras Ivan⁶,Janikova Katarina³,Kasubova Ivana³,Samec Marek⁷,Brany Dusan³,Lyskova Darina⁸,Valaskova Jela⁸,Dankova Zuzana³,Smolkova Bozena⁴^ORCID,Furdova Alena⁷

Affiliation:

1. Department of Molecular Biology Faculty of Natural Sciences, Comenius University in Bratislava Bratislava Slovakia

2. Institute for Clinical and Translational Research Biomedical Research Center, Slovak Academy of Sciences Bratislava Slovakia

3. Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovakia

4. Department of Molecular Oncology Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences Bratislava Slovakia

5. Department of Pathology Faculty of Medicine, Comenius University in Bratislava Bratislava Slovakia

6. Lambda Life a.s. Bratislava Slovakia

7. Department of Pathophysiology, Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovakia

8. Department of Ophthalmology Faculty of Medicine, Comenius University in Bratislava Bratislava Slovakia

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1317

Reference10 articles.

1. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

2. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

3. Loss ofBAP1expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development